Related Experiment Video
Updated: May 14, 2026

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application
Published on: July 9, 2020
PTCA with drug-coated balloons is associated with immediate decrease of coronary flow reserve
Mabelle Young1, Florim Cuculi, Paul Erne
1Department of Cardiology, Luzerner Kantonsspital, Luzern, Switzerland.
Insights
Drug-coated balloons (DCB) temporarily decrease coronary flow reserve (CFR) immediately after use, but this effect resolves within 10 minutes. Further research is needed to understand the long-term implications of this acute CFR drop.
Area of Science:
- Interventional Cardiology
- Cardiovascular Research
Background:
- Drug-coated balloons (DCB) are increasingly utilized in interventional cardiology procedures.
- The acute impact of DCB on coronary flow reserve (CFR) has not been previously documented.
Purpose of the Study:
- To investigate the immediate effects of DCB on coronary flow reserve (CFR).
- To assess the temporal changes in CFR following DCB application.
Main Methods:
- Coronary flow reserve (CFR) was measured using the FloWire in patients undergoing procedures for in-stent restenosis or with clopidogrel contraindications.
- CFR was assessed before and after conventional balloon angioplasty, and subsequently after the use of a paclitaxel-eluting DCB (In.Pact).
- In a subset of patients, CFR was serially measured up to 10 minutes post-DCB implantation.
Main Results:
- A total of 32 lesions in 30 patients were analyzed.
- Conventional balloon angioplasty did not significantly alter CFR (P = 0.95).
- The use of In.Pact DCB resulted in a significant acute decrease in CFR (1.59 ± 0.49 to 1.22 ± 0.28, P < 0.0001).
- CFR demonstrated a statistically significant improvement within 10 minutes post-DCB in a subgroup of patients (P = 0.01).
- Subsequent coronary stent implantation rapidly restored CFR (P = 0.0004).
Conclusions:
- A novel observation of an acute, transient decrease in CFR following DCB use is reported.
- The observed reduction in CFR is temporary, with spontaneous recovery occurring around 10 minutes.
- The underlying pathophysiological mechanisms require further investigation, alongside studies on the long-term consequences of this acute effect.
Introduction:
Drug-coated balloons (DCB) are being increasingly used in interventional cardiology. The effect of DCB on acute changes of coronary flow reserve (CFR) has never been reported.
Methods:
Patients with in-stent restenosis or with contraindication for use of clopidogrel were included in this study. The FloWire was used to assess CFR before and immediately after conventional balloon angioplasty and after the use of In.Pact, a paclitaxel-coated balloon. In a sub-selection of patients, CFR was measured immediately and then 2, 5, and 10 min post-DCB.
Results:
Thirty patients (18 males, 60%) with a total of 32 lesions were studied. Comparison of CFR pre- and post-conventional balloon angioplasty was not statistically significant (P = 0.95). CFR dropped significantly after the use of In.Pact (n = 32, 1.59 ± 0.49 vs. 1.22 ± 0.28, P < 0.0001) and showed a statistically significant improvement over 10 min in a subset of patients (n = 6, P = 0.01). Implantation of a coronary stent after the use of In.Pact rapidly improved CFR (n = 10, P = 0.0004).
Conclusions:
We describe a novel phenomenon of acute decrease in CFR after the use of DCB. This phenomenon is temporary and spontaneously improves after approximately 10 min. The exact pathophysiological mechanism remains unclear and further studies are warranted to study the long-term effects of acute CFR drop after use of DCB.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
07:46Bilateral Common Carotid Artery Occlusion as an Adequate Preconditioning Stimulus to Induce Early Ischemic Tolerance to Focal Cerebral Ischemia
Published on: May 9, 2013
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Acute Coronary Syndrome IV: Interprofessional Care
Imaging Studies for Cardiovascular System V: CT